Antigen Information
General Information of This Antigen
| Antigen ID | TAR0ZHRFU |
|||||
|---|---|---|---|---|---|---|
| Antigen Name | Glutamate carboxypeptidase 2 (FOLH1) |
|||||
| Gene Name | FOLH1 |
|||||
| Gene ID | ||||||
| Synonym | Cell growth-inhibiting gene 27 protein; Folate hydrolase 1; Folylpoly-gamma-glutamate carboxypeptidase; Glutamate carboxypeptidase II; Membrane glutamate carboxypeptidase; N-acetylated-alpha-linked acidic dipeptidase I; Prostate-specific membrane antigen; Pteroylpoly-gamma-glutamate carboxypeptidase |
|||||
| Sequence |
MWNLLHETDSAVA.RPRWLCAGALVLAGGFFLLGFLFGWFIKSSNEATNITPKHNMKAFL
DELKAENIKKFLYNFTQIPHLAGTEQNFQLAKQIQSQWKEFGLDSVELAHYDVLLSYPNK THPNYISIINEDGNEIFNTSLFEPPPPGYENVSDIVPPFSAFSPQGMPEGDLVYVNYART EDFFKLERDMKINCSGKIVIARYGKVFRGNKVKNAQLAGAKGVILYSDPADYFAPGVKSY PDGWNLPGGGVQRGNILNLNGAGDPLTPGYPANEYAYRRGIAEAVGLPSIPVHPIGYYDA QKLLEKMGGSAPPDSSWRGSLKVPYNVGPGFTGNFSTQKVKMHIHSTNEVTRIYNVIGTL RGAVEPDRYVILGGHRDSWVFGGIDPQSGAAVVHEIVRSFGTLKKEGWRPRRTILFASWD AEEFGLLGSTEWAEENSRLLQERGVAYINADSSIEGNYTLRVDCTPLMYSLVHNLTKELK SPDEGFEGKSLYESWTKKSPSPEFSGMPRISKLGSGNDFEVFFQRLGIASGRARYTKNWE TNKFSGYPLYHSVYETYELVEKFYDPMFKYHLTVAQVRGGMVFELANSIVLPFDCRDYAV VLRKYADKIYSISMKHPQEMKTYSVSFDSLFSAVKNFTEIASKFSERLQDFDKSNPIVLR MMNDQLMFLERAFIDPLGLPDRPFYRHVIYAPSSHNKYAGESFPGIYDALFDIESKVDPS KAWGEVKRQIYVAAFTVQAAAETLSEVA Click to Show/Hide
|
|||||
| Family | Peptidase M28 family |
|||||
| Function |
Has both folate hydrolase and N-acetylated-alpha-linked- acidic dipeptidase (NAALADase) activity. Has a preference for tri- alpha-glutamate peptides. In the intestine, required for the uptake of folate. In the brain, modulates excitatory neurotransmission through the hydrolysis of the neuropeptide, N-aceylaspartylglutamate (NAAG), thereby releasing glutamate. Involved in prostate tumor progression.; Also exhibits a dipeptidyl-peptidase IV type activity. In vitro, cleaves Gly-Pro-AMC.
Click to Show/Hide
|
|||||
| Uniprot Entry | ||||||
| HGNC ID | ||||||
| KEGG ID | ||||||
Each Antibody-drug Conjuate AND It's Component Related to This Antigen
Full List of The ADC Related to This Antigen
5D3 mAb
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
38751786 5D3 (CC-MLB8237)3.2 ATC
[1]
|
MLN8237 |
Undisclosed |
NHS-PEG-TCO-Tz |
5D3 mAb-AF488
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
38751786 5D3 (CC-MLB8237)3.2-AF488
[1]
|
MLN8237 |
Undisclosed |
NHS-PEG-TCO-Tz |
5D3 mAb-AF555
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
38751786 5D3 (CC-MLB8237)3.2-AF555
[1]
|
MLN8237 |
Undisclosed |
NHS-PEG-TCO-Tz |
5D3 mAb-CF750
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
38751786 5D3 (CC-MLB8237)3.2-CF750
[1]
|
MLN8237 |
Undisclosed |
NHS-PEG-TCO-Tz |
7E11 C5
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
Monoclonal antibody 7E11 C5-selenocystamine conjugate
[2]
|
Undisclosed |
Undisclosed |
Undisclosed |
Anti-H8
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
H8-LD12
[3]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
H8-LD3
[3]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
H8-LD4
[3]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
H8-LD5
[3]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
H8-LD6
[3]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
H8-LD7
[3]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
H8-LD8
[3]
|
Undisclosed |
Undisclosed |
Undisclosed |
Anti-PSMA
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
PSMA -LD12
[3]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
PSMA -LD3
[3]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
PSMA -LD4
[3]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
PSMA -LD5
[3]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
PSMA -LD6
[3]
|
Undisclosed |
Undisclosed |
Undisclosed |
Anti-PSMA antibody
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
MHB048C
[4]
|
MH30010008 |
DNA topoisomerase 1 (TOP1) |
Undisclosed |
Anti-PSMA IgG1 mAb D2B
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
111In-DTPA-D2B-DAR2-MMAE
[5]
|
Monomethyl auristatin E |
Microtubule (MT) |
Mc-Val-Cit-PABC |
|
|
111In-DTPA-D2B-DAR4-MMAE
[5]
|
Monomethyl auristatin E |
Microtubule (MT) |
Mc-Val-Cit-PABC |
Anti-PSMA IgG1k mAb
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
JNJ-95298177
|
Amberstatin 269 (AS269) |
Microtubule (MT) |
Oxime-PEG3 |
Anti-PSMA mAb
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
PSMA-15
[6]
|
DM1 derivative 15 |
Microtubule (MT) |
Mc-Val-Cit-PABC |
|
|
PSMA-16
[6]
|
DM1 derivative 16 |
Microtubule (MT) |
Mc-Val-Cit-PABC |
|
|
SHR-4394
|
SHR9265 |
DNA topoisomerase 1 (TOP1) |
A cleavable linker |
Anti-PSMA mAb 5D3
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
111In-DOTA-5D3
[7]
|
Indium-111 |
Human Deoxyribonucleic acid (hDNA) |
Tetraxetan |
Anti-PSMA mAb D2B
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
D2B-DCM
[8]
|
Duocarmycin A |
Human Deoxyribonucleic acid (hDNA) |
Mc-Val-Cit-PABC |
Anti-PSMA mAb h3/F11-Var16
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
H3/F11-Var16 (Anti-PSMA)-30.2060
[9]
|
Amanitin 30.206 |
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G) |
Mc-Val-Ala-PABC |
|
|
H3/F11-Var16 (Anti-PSMA)-30.2867
[9]
|
Amanitin 30.2867 |
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G) |
Maleimido-caproyl |
Anti-PSMA mAb hD7-1
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
HD7-1 (VL-VH)-PE40
[10]
|
Pseudomonas exotoxin PE40 |
Eukaryotic elongation factor 2 kinase (EEF2K) |
Undisclosed |
|
|
HD7-1 (VL-VH)-PE24
[10]
|
Pseudomonas exotoxin PE24 |
Eukaryotic elongation factor 2 kinase (EEF2K) |
Undisclosed |
|
|
HD7-1 (VL-VH)-PE24mut
[10]
|
Pseudomonas exotoxin PE24 mut |
Eukaryotic elongation factor 2 kinase (EEF2K) |
Undisclosed |
Anti-PSMA mAb wt
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
SYD998
[11]
|
seco-DUBA |
Human Deoxyribonucleic acid (hDNA) |
Mal-PEG2-Val-Cit-PABA-Cyclization Spacer |
|
|
WO2015177360A1 ADC-wt-vcMMAE
[11]
|
Monomethyl auristatin E |
Microtubule (MT) |
Mc-Val-Cit-PABC |
|
|
WO2015177360A1 ADC-wt-mcMMAF
[11]
|
Monomethyl auristatin F |
Microtubule (MT) |
Maleimido-caproyl |
Anti-PSMA mAb wt HC A339C
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
WO2015177360A1 ADC-HC339
[11]
|
seco-DUBA |
Human Deoxyribonucleic acid (hDNA) |
Mal-PEG2-Val-Cit-PABA-Cyclization Spacer |
Anti-PSMA mAb wt HC D376C
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
WO2015177360A1 ADC-HC376
[11]
|
seco-DUBA |
Human Deoxyribonucleic acid (hDNA) |
Mal-PEG2-Val-Cit-PABA-Cyclization Spacer |
Anti-PSMA mAb wt HC E152C
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
WO2015177360A1 ADC-HC152
[11]
|
seco-DUBA |
Human Deoxyribonucleic acid (hDNA) |
Mal-PEG2-Val-Cit-PABA-Cyclization Spacer |
Anti-PSMA mAb wt HC G236C
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
WO2015177360A1 ADC-HC236
[11]
|
seco-DUBA |
Human Deoxyribonucleic acid (hDNA) |
Mal-PEG2-Val-Cit-PABA-Cyclization Spacer |
Anti-PSMA mAb wt HC P153C
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
WO2015177360A1 ADC-HC153
[11]
|
seco-DUBA |
Human Deoxyribonucleic acid (hDNA) |
Mal-PEG2-Val-Cit-PABA-Cyclization Spacer |
Anti-PSMA mAb wt HC P247C
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
WO2015177360A1 ADC-HC247
[11]
|
seco-DUBA |
Human Deoxyribonucleic acid (hDNA) |
Mal-PEG2-Val-Cit-PABA-Cyclization Spacer |
Anti-PSMA mAb wt HC S375C
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
WO2015177360A1 ADC-HC375
[11]
|
seco-DUBA |
Human Deoxyribonucleic acid (hDNA) |
Mal-PEG2-Val-Cit-PABA-Cyclization Spacer |
Anti-PSMA mAb wt HC S41C
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
SYD1091
[11]
|
seco-DUBA |
Human Deoxyribonucleic acid (hDNA) |
Mal-PEG2-Val-Cit-PABA-Cyclization Spacer |
|
|
WO2015177360A1 ADC-HC41-vcMMAE
[11]
|
Monomethyl auristatin E |
Microtubule (MT) |
Mc-Val-Cit-PABC |
|
|
WO2015177360A1 ADC-HC41-mcMMAF
[11]
|
Monomethyl auristatin F |
Microtubule (MT) |
Maleimido-caproyl |
Anti-PSMA mAb wt HC S41C/S375C
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
WO2015177360A1 ADC-HC41-375
[11]
|
seco-DUBA |
Human Deoxyribonucleic acid (hDNA) |
Mal-PEG2-Val-Cit-PABA-Cyclization Spacer |
Anti-PSMA mAb wt HC S41C/T120C
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
WO2015177360A1 ADC-HC41-120
[11]
|
seco-DUBA |
Human Deoxyribonucleic acid (hDNA) |
Mal-PEG2-Val-Cit-PABA-Cyclization Spacer |
Anti-PSMA mAb wt HC T120C
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
SYD1035
[11]
|
seco-DUBA |
Human Deoxyribonucleic acid (hDNA) |
Mal-PEG2-Val-Cit-PABA-Cyclization Spacer |
Anti-PSMA mAb wt LC E165C
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
WO2015177360A1 ADC-LC205
[11]
|
seco-DUBA |
Human Deoxyribonucleic acid (hDNA) |
Mal-PEG2-Val-Cit-PABA-Cyclization Spacer |
Anti-PSMA mAb wt LC G157C
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
WO2015177360A1 ADC-LC157
[11]
|
seco-DUBA |
Human Deoxyribonucleic acid (hDNA) |
Mal-PEG2-Val-Cit-PABA-Cyclization Spacer |
Anti-PSMA mAb wt LC G41C
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
WO2015177360A1 ADC-LC41
[11]
|
seco-DUBA |
Human Deoxyribonucleic acid (hDNA) |
Mal-PEG2-Val-Cit-PABA-Cyclization Spacer |
|
|
WO2015177360A1 ADC-LC41-vcMMAE
[11]
|
Monomethyl auristatin E |
Microtubule (MT) |
Mc-Val-Cit-PABC |
|
|
WO2015177360A1 ADC-LC41-mcMMAF
[11]
|
Monomethyl auristatin F |
Microtubule (MT) |
Maleimido-caproyl |
Anti-PSMA mAb wt LC L154C
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
WO2015177360A1 ADC-LC165
[11]
|
seco-DUBA |
Human Deoxyribonucleic acid (hDNA) |
Mal-PEG2-Val-Cit-PABA-Cyclization Spacer |
Anti-PSMA mAb wt LC P40C
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
WO2015177360A1 ADC-LC154
[11]
|
seco-DUBA |
Human Deoxyribonucleic acid (hDNA) |
Mal-PEG2-Val-Cit-PABA-Cyclization Spacer |
|
|
WO2015177360A1 ADC-LC40-vcMMAE
[11]
|
Monomethyl auristatin E |
Microtubule (MT) |
Mc-Val-Cit-PABC |
|
|
WO2015177360A1 ADC-LC40-mcMMAF
[11]
|
Monomethyl auristatin F |
Microtubule (MT) |
Maleimido-caproyl |
Anti-PSMA mAb wt LC T109C
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
WO2015177360A1 ADC-LC109
[11]
|
seco-DUBA |
Human Deoxyribonucleic acid (hDNA) |
Mal-PEG2-Val-Cit-PABA-Cyclization Spacer |
Anti-PSMA mAb wt LC V205C
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
WO2015177360A1 ADC-LC40
[11]
|
seco-DUBA |
Human Deoxyribonucleic acid (hDNA) |
Mal-PEG2-Val-Cit-PABA-Cyclization Spacer |
Anti-PSMA scFv
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
124I-scFvD2B
[12]
|
Iodine I-124 |
Undisclosed |
Undisclosed |
Anti-PSMA-D265C
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
Anti-PSMA-D265C-30.2060
[9]
|
Amanitin 30.206 |
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G) |
Mc-Val-Ala-PABC |
|
|
Anti-PSMA-D265C-30.2115
[9]
|
Amanitin 30.2115 |
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G) |
Mc-Val-Ala-PABC |
|
|
Anti-PSMA-D265C-30.2347
[9]
|
Amanitin 30.2347 |
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G) |
Mc-Val-Ala-PABC |
|
|
Anti-PSMA-D265C-30.1699
[9]
|
Amanitin 30.1699 |
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G) |
Mc-Val-Ala-PABC |
|
|
Anti-PSMA-D265C-30.2371
[9]
|
Amanitin 30.2371 |
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G) |
Mc-Val-Ala-PABC |
|
|
Anti-PSMA-D265C-30.0880
[9]
|
Amanitin 30.088 |
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G) |
Maleimido-caproyl |
|
|
Anti-PSMA-D265C-30.2867
[9]
|
Amanitin 30.2867 |
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G) |
Maleimido-caproyl |
Anti-PSMA-HC1205
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
PSMA-HC1205-LD12
[3]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
PSMA-HC1205-LD3
[3]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
PSMA-HC1205-LD4
[3]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
PSMA-HC1205-LD5
[3]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
PSMA-HC1205-LD6
[3]
|
Undisclosed |
Undisclosed |
Undisclosed |
Anti-PSMA-HC41
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
PSMA-HC41-LD12
[3]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
PSMA-HC41-LD3
[3]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
PSMA-HC41-LD4
[3]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
PSMA-HC41-LD5
[3]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
PSMA-HC41-LD6
[3]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
PSMA-HC41-LD7
[3]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
PSMA-HC41-LD8
[3]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
PSMA-HC41-LD9
[3]
|
Undisclosed |
Undisclosed |
PSMA-HC41-LD9 LINKER |
|
|
PSMA-HC41-LD10
[3]
|
Undisclosed |
Undisclosed |
Trastuzumab-LD1-LINKER |
|
|
PSMA-HC41-LD36
[3]
|
seco-DUBA |
Human Deoxyribonucleic acid (hDNA) |
PSMA-HC41-LD36 LINKER |
|
|
PSMA-HC41-LD64
[3]
|
PSMA-HC41-LD64 payload |
Undisclosed |
PSMA-HC41-LD64 LINKER |
Anti-PSMA-LC40
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
PSMA-LC40-LD12
[3]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
PSMA-LC40-LD3
[3]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
PSMA-LC40-LD4
[3]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
PSMA-LC40-LD5
[3]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
PSMA-LC40-LD6
[3]
|
Undisclosed |
Undisclosed |
Undisclosed |
Anti-PSMA-LC41
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
PSMA-LC41-LD12
[3]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
PSMA-LC41-LD3
[3]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
PSMA-LC41-LD4
[3]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
PSMA-LC41-LD5
[3]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
PSMA-LC41-LD6
[3]
|
Undisclosed |
Undisclosed |
Undisclosed |
Anti-PSMA1
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
PSMA1 -LD12
[3]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
PSMA 1-LD3
[3]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
PSMA 1-LD4
[3]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
PSMA 1-LD5
[3]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
PSMA 1-LD6
[3]
|
Undisclosed |
Undisclosed |
Undisclosed |
Chimeric Anti-PSMA Antibody
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
EP4461318A2 anti-PSMA ADC11
[13]
|
Monomethyl auristatin E |
Microtubule (MT) |
Undisclosed |
|
|
EP4461318A2 anti-PSMA ADC12
[13]
|
Monomethyl auristatin F |
Microtubule (MT) |
Undisclosed |
|
|
EP4461318A2 anti-PSMA ADC13
[13]
|
Monomethyl auristatin F |
Microtubule (MT) |
CLeavable (Val-Citruline-PEG1) linker |
|
|
EP4461318A2 anti-PSMA ADC14
[13]
|
Monomethyl auristatin F |
Microtubule (MT) |
Short Cleavable (Valine-Citruline-Acetyl) |
|
|
EP4461318A2 anti-PSMA ADC15
[13]
|
Monomethyl auristatin E |
Microtubule (MT) |
Short Cleavable (Valine-Citruline-Acetyl) |
D10
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
SDV2102
[14]
|
Monomethyl auristatin E |
Microtubule (MT) |
Undisclosed |
Fully human anti-PSMA IgG1 mAb
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
PSMA ADC
|
MMAE |
Microtubule (MT) |
Mc-Val-Cit-PABC |
HuJ591
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
TD001
[15]
|
Exatecan |
DNA topoisomerase 1 (TOP1) |
A cleavable linker |
Humanized Anti-PSMA Antibody Variant 1
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
EP4461318A2 anti-PSMA ADC1
[13]
|
Monomethyl auristatin E |
Microtubule (MT) |
Undisclosed |
|
|
EP4461318A2 anti-PSMA ADC2
[13]
|
Monomethyl auristatin F |
Microtubule (MT) |
Undisclosed |
|
|
EP4461318A2 anti-PSMA ADC3
[13]
|
Monomethyl auristatin F |
Microtubule (MT) |
CLeavable (Val-Citruline-PEG1) linker |
|
|
EP4461318A2 anti-PSMA ADC4
[13]
|
Monomethyl auristatin F |
Microtubule (MT) |
Short Cleavable (Valine-Citruline-Acetyl) |
|
|
EP4461318A2 anti-PSMA ADC5
[13]
|
Monomethyl auristatin E |
Microtubule (MT) |
Short Cleavable (Valine-Citruline-Acetyl) |
Humanized Anti-PSMA Antibody Variant 2
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
EP4461318A2 anti-PSMA ADC6
[13]
|
Monomethyl auristatin E |
Microtubule (MT) |
Undisclosed |
|
|
EP4461318A2 anti-PSMA ADC7
[13]
|
Monomethyl auristatin F |
Microtubule (MT) |
Undisclosed |
|
|
EP4461318A2 anti-PSMA ADC8
[13]
|
Monomethyl auristatin F |
Microtubule (MT) |
CLeavable (Val-Citruline-PEG1) linker |
|
|
EP4461318A2 anti-PSMA ADC9
[13]
|
Monomethyl auristatin F |
Microtubule (MT) |
Short Cleavable (Valine-Citruline-Acetyl) |
|
|
EP4461318A2 anti-PSMA ADC10
[13]
|
Monomethyl auristatin E |
Microtubule (MT) |
Short Cleavable (Valine-Citruline-Acetyl) |
Humanized anti-PSMA IgG1k mAb
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
ARX-517
|
Amberstatin-269 |
Undisclosed |
Oxime-PEG3 |
J591
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
MEDI3726
|
SG3199 (SC-DR002) |
Human deoxyribonucleic acid (hDNA) |
Mal-PEG8-Val-Ala-PABC |
|
|
YC1613
[16]
|
Active metabolite of irinotecan SN38 |
DNA topoisomerase 1 (TOP1) |
Ab-MC-VC-PAB-DMEDA-PEG (N3)-SN38 Linker |
|
|
YC1628
[16]
|
Active metabolite of irinotecan SN38 |
DNA topoisomerase 1 (TOP1) |
Ab-MP2-VC-PAB-DMEDA-PEG (N3)-SN38 Linker |
|
|
YC1605
[16]
|
Monomethyl auristatin E |
Microtubule (MT) |
Mc-Val-Cit-PABC |
|
|
YC1667
[16]
|
MK4827 |
Undisclosed |
Ab-MC-MMAF-VC-PAB-MK4827 Linker |
|
|
YC1663
[16]
|
Active metabolite of irinotecan SN38 |
DNA topoisomerase 1 (TOP1) |
Ab-MC-MMAF-VC-PAB-DMEDA-PEG (N3)-SN38 Linker |
J591 THIOMAB
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
J591 DAC
[17]
|
GNE-987 (R) |
Bromodomain-containing protein 4 (BRD4) |
Mc-Gly-Gly-Phe-Gly |
J591-SC239C
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
PSMA-D Antibody-Compound (X)
[18]
|
PSMA-D Antibody-Compound (X) payload |
Undisclosed |
PSMA-D Antibody-Compound (X) linker |
|
|
PSMA-D Antibody-Compound (XI)
[18]
|
PSMA-D Antibody-Compound (XI) payload |
Undisclosed |
PSMA-D Antibody-Compound (XI) linker |
|
|
PSMA-D Antibody-Compound (XIV)
[18]
|
PSMA-D Antibody-Compound (XIV) payload |
Undisclosed |
PSMA-D Antibody-Compound (XIV) linker |
|
|
PSMA-D Antibody-Compound (XVIII)
[18]
|
PSMA-D Antibody-Compound (XVIII) payload |
Undisclosed |
PSMA-D Antibody-Compound (XVIII) linker |
|
|
PSMA-D Antibody-Compound (Ie)
[18]
|
PSMA-D Antibody-Compound (Ie) payload |
Undisclosed |
PSMA-D Antibody-Compound (Ie) linker |
|
|
PSMA-D Antibody-Compound (XIX)
[18]
|
PSMA-D Antibody-Compound (XIX) payload |
Undisclosed |
PSMA-D Antibody-Compound (XIX) linker |
|
|
PSMA-D Antibody-Compound (Ii)
[18]
|
PSMA-D Antibody-Compound (Ii) payload |
Undisclosed |
PSMA-D Antibody-Compound (Ii) linker |
|
|
PSMA-D Antibody-Compound (XLI)
[18]
|
PSMA-D Antibody-Compound (XLI) payload |
Undisclosed |
PSMA-D Antibody-Compound (XLI) linker |
|
|
PSMA-D Antibody-Compound (XVI)
[18]
|
PSMA-D Antibody-Compound (XIX) payload |
Undisclosed |
PSMA-D Antibody-Compound (XIX) linker |
|
|
PSMA-D Antibody-Compound (XL)
[18]
|
PSMA-D Antibody-Compound (XL) payload |
Undisclosed |
PSMA-D Antibody-Compound (XL) linker |
|
|
PSMA-D Antibody-Compound (XLIII)
[18]
|
PSMA-D Antibody-Compound (XLIII) payload |
Undisclosed |
PSMA-D Antibody-Compound (XLIII) linker |
|
|
PSMA-D Antibody-Compound (XLII)
[18]
|
PSMA-D Antibody-Compound (XLII) payload |
Undisclosed |
PSMA-D Antibody-Compound (XLII) linker |
|
|
J591-SC239C-Compound (XV)
[18]
|
J591-SC239C-Compound (XV) payload |
Undisclosed |
J591-SC239C-Compound (XV) linker |
MLN591
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
MLN2704
|
DM1 |
Microtubule (MT) |
N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP) |
PSMA-A Anti-ody
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
PSMA-A Antibody-Compound (X)
[18]
|
PSMA-A Antibody-Compound (X) payload |
Undisclosed |
PSMA-A Antibody-Compound (X) linker |
|
|
PSMA-A Antibody-Compound (XI)
[18]
|
PSMA-A Antibody-Compound (XI) payload |
Undisclosed |
PSMA-A Antibody-Compound (XI) linker |
|
|
PSMA-A Antibody-Compound (XIV)
[18]
|
PSMA-A Antibody-Compound (XIV) payload |
Undisclosed |
PSMA-A Antibody-Compound (XIV) linker |
|
|
PSMA-A Antibody-Compound (XVIII)
[18]
|
PSMA-A Antibody-Compound (XVIII) payload |
Undisclosed |
PSMA-A Antibody-Compound (XVIII) linker |
|
|
PSMA-A Antibody-Compound (Ie)
[18]
|
PSMA-A Antibody-Compound (Ie) payload |
Undisclosed |
PSMA-A Antibody-Compound (Ie) linker |
|
|
PSMA-A Antibody-Compound (XIX)
[18]
|
PSMA-A Antibody-Compound (XIX) payload |
Undisclosed |
PSMA-A Antibody-Compound (XIX) linker |
|
|
PSMA-A Antibody-Compound (Ii)
[18]
|
PSMA-A Antibody-Compound (Ii) payload |
Undisclosed |
PSMA-A Antibody-Compound (Ii) linker |
|
|
PSMA-A Antibody-Compound (XLI)
[18]
|
PSMA-A Antibody-Compound (XLI) payload |
Undisclosed |
PSMA-A Antibody-Compound (XLI) linker |
|
|
PSMA-A Antibody-Compound (XVI)
[18]
|
PSMA-A Antibody-Compound (XIX) payload |
Undisclosed |
PSMA-A Antibody-Compound (XIX) linker |
|
|
PSMA-A Antibody-Compound (XL)
[18]
|
PSMA-A Antibody-Compound (XL) payload |
Undisclosed |
PSMA-A Antibody-Compound (XL) linker |
|
|
PSMA-A Antibody-Compound (XLIII)
[18]
|
PSMA-A Antibody-Compound (XLIII) payload |
Undisclosed |
PSMA-A Antibody-Compound (XLIII) linker |
|
|
PSMA-A Antibody-Compound (XLII)
[18]
|
PSMA-A Antibody-Compound (XLII) payload |
Undisclosed |
PSMA-A Antibody-Compound (XLII) linker |
|
|
PSMA-A Antibody-Compound (XV)
[18]
|
PSMA-A Antibody-Compound (XV) payload |
Undisclosed |
PSMA-A Antibody-Compound (XV) linker |
PSMA-B Anti-ody
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
PSMA-B Antibody-Compound (X)
[18]
|
PSMA-B Antibody-Compound (X) payload |
Undisclosed |
PSMA-B Antibody-Compound (X) linker |
|
|
PSMA-B Antibody-Compound (XI)
[18]
|
PSMA-B Antibody-Compound (XI) payload |
Undisclosed |
PSMA-B Antibody-Compound (XI) linker |
|
|
PSMA-B Antibody-Compound (XIV)
[18]
|
PSMA-B Antibody-Compound (XIV) payload |
Undisclosed |
PSMA-B Antibody-Compound (XIV) linker |
|
|
PSMA-B Antibody-Compound (XVIII)
[18]
|
PSMA-B Antibody-Compound (XVIII) payload |
Undisclosed |
PSMA-B Antibody-Compound (XVIII) linker |
|
|
PSMA-B Antibody-Compound (Ie)
[18]
|
PSMA-B Antibody-Compound (Ie) payload |
Undisclosed |
PSMA-B Antibody-Compound (Ie) linker |
|
|
PSMA-B Antibody-Compound (XIX)
[18]
|
PSMA-B Antibody-Compound (XIX) payload |
Undisclosed |
PSMA-B Antibody-Compound (XIX) linker |
|
|
PSMA-B Antibody-Compound (Ii)
[18]
|
PSMA-B Antibody-Compound (Ii) payload |
Undisclosed |
PSMA-B Antibody-Compound (Ii) linker |
|
|
PSMA-B Antibody-Compound (XLI)
[18]
|
PSMA-B Antibody-Compound (XLI) payload |
Undisclosed |
PSMA-B Antibody-Compound (XLI) linker |
|
|
PSMA-B Antibody-Compound (XVI)
[18]
|
PSMA-B Antibody-Compound (XIX) payload |
Undisclosed |
PSMA-B Antibody-Compound (XIX) linker |
|
|
PSMA-B Antibody-Compound (XL)
[18]
|
PSMA-B Antibody-Compound (XL) payload |
Undisclosed |
PSMA-B Antibody-Compound (XL) linker |
|
|
PSMA-B Antibody-Compound (XLIII)
[18]
|
PSMA-B Antibody-Compound (XLIII) payload |
Undisclosed |
PSMA-B Antibody-Compound (XLIII) linker |
|
|
PSMA-B Antibody-Compound (XLII)
[18]
|
PSMA-B Antibody-Compound (XLII) payload |
Undisclosed |
PSMA-B Antibody-Compound (XLII) linker |
|
|
PSMA-B Antibody-Compound (XV)
[18]
|
PSMA-B Antibody-Compound (XV) payload |
Undisclosed |
PSMA-B Antibody-Compound (XV) linker |
PSMA-C Anti-ody
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
PSMA-C Antibody-Compound (X)
[18]
|
PSMA-C Antibody-Compound (X) payload |
Undisclosed |
PSMA-C Antibody-Compound (X) linker |
|
|
PSMA-C Antibody-Compound (XI)
[18]
|
PSMA-C Antibody-Compound (XI) payload |
Undisclosed |
PSMA-C Antibody-Compound (XI) linker |
|
|
PSMA-C Antibody-Compound (XIV)
[18]
|
PSMA-C Antibody-Compound (XIV) payload |
Undisclosed |
PSMA-C Antibody-Compound (XIV) linker |
|
|
PSMA-C Antibody-Compound (XVIII)
[18]
|
PSMA-C Antibody-Compound (XVIII) payload |
Undisclosed |
PSMA-C Antibody-Compound (XVIII) linker |
|
|
PSMA-C Antibody-Compound (Ie)
[18]
|
PSMA-C Antibody-Compound (Ie) payload |
Undisclosed |
PSMA-C Antibody-Compound (Ie) linker |
|
|
PSMA-C Antibody-Compound (XIX)
[18]
|
PSMA-C Antibody-Compound (XIX) payload |
Undisclosed |
PSMA-C Antibody-Compound (XIX) linker |
|
|
PSMA-C Antibody-Compound (Ii)
[18]
|
PSMA-C Antibody-Compound (Ii) payload |
Undisclosed |
PSMA-C Antibody-Compound (Ii) linker |
|
|
PSMA-C Antibody-Compound (XLI)
[18]
|
PSMA-C Antibody-Compound (XLI) payload |
Undisclosed |
PSMA-C Antibody-Compound (XLI) linker |
|
|
PSMA-C Antibody-Compound (XVI)
[18]
|
PSMA-C Antibody-Compound (XIX) payload |
Undisclosed |
PSMA-C Antibody-Compound (XIX) linker |
|
|
PSMA-C Antibody-Compound (XL)
[18]
|
PSMA-C Antibody-Compound (XL) payload |
Undisclosed |
PSMA-C Antibody-Compound (XL) linker |
|
|
PSMA-C Antibody-Compound (XLIII)
[18]
|
PSMA-C Antibody-Compound (XLIII) payload |
Undisclosed |
PSMA-C Antibody-Compound (XLIII) linker |
|
|
PSMA-C Antibody-Compound (XLII)
[18]
|
PSMA-C Antibody-Compound (XLII) payload |
Undisclosed |
PSMA-C Antibody-Compound (XLII) linker |
|
|
PSMA-C Antibody-Compound (XV)
[18]
|
PSMA-C Antibody-Compound (XV) payload |
Undisclosed |
PSMA-C Antibody-Compound (XV) linker |
Rosopatamab
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
Rosopatamab tetraxetan
[19]
|
Y90 (Radioactive isotope) |
Undisclosed |
Tetraxetan |
Undisclosed
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
Anti-PSMA antibody-drug conjugate (Protanbio)
[20]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
PSMA ADC (Jiangsu hengrui)
[21]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
Anti-PSMA antibody-deBouganin fusion protein (Crescendo/Sesen Bio)
[22]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
HDP-103
[23]
|
Alpha-amanitin |
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G) |
Undisclosed |
|
|
DAN-405
[24]
|
Cabazitaxel |
Microtubule (MT) |
Undisclosed |
|
|
MMAE.VC.SA.617
[25]
|
Monomethyl auristatin E |
Microtubule (MT) |
Undisclosed |
|
|
Anti-PSMA antibody-drug conjugate
[26]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
CB-108
[27]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
WO2024118785A3 Lot41
[28]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
WO2024118785A3 Lot42
[28]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
WO2024118785A3 Lot55
[28]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
WO2024118785A3 Lot75
[28]
|
Undisclosed |
Undisclosed |
Undisclosed |
References
